Correlation Between Hemochron and Istat in Cardiac Surgery (CHIC Study)
Sponsored by Hospices Civils de Lyon
About this trial
Last updated 4 years ago
Study ID
69HCL19_0381
Status
Completed
Type
Observational
Placebo
No
Accepting
All
All
Trial Timing
Ended 4 years ago
What is this trial about?
Cardiac surgery needs the use of cardiopulmonary bypass. During this time, it is
necessary to prevent thrombosis with high level of heparin and to control the good
efficiency with a point of care test. Investigators want to test if two different
devices, Hemochron and Istat, are giving similar results.
What are the participation requirements?
Inclusion Criteria
- adults or children
- Supported in the Department of Anesthesia - Resuscitation of the Louis Pradel Hospital (Lyon, France) for cardiac surgery with or without cardiopulmonary bypass
- Patient or Parents / Holders of parental authority informed and not opposed to participate in the study
Exclusion Criteria
- patient with heparin-induced thrombocytopenia
- patient receiving antiplatelet therapy targeting GpIIbIIIa receptors